Department Of Medicine 10
451. Modeling tuberculosis transmission dynamics in Kazakhstan using SARIMA and SIR models
452. Access to prediabetes care: A SAFES statement
453. Access to prediabetes care: A SAFES statement
454. A second update on mapping the human genetic architecture of COVID-19
455. A second update on mapping the human genetic architecture of COVID-19
456. A second update on mapping the human genetic architecture of COVID-19
457. A second update on mapping the human genetic architecture of COVID-19
458. An update review of post-transplant diabetes mellitus: Concept, risk factors, clinical implications and management
459. An update review of post-transplant diabetes mellitus: Concept, risk factors, clinical implications and management
460. An update review of post-transplant diabetes mellitus: Concept, risk factors, clinical implications and management
461. An update review of post-transplant diabetes mellitus: Concept, risk factors, clinical implications and management
462. Effect of tirzepatide on blood pressure and lipids: A meta-analysis of randomized controlled trials
463. Effect of tirzepatide on blood pressure and lipids: A meta-analysis of randomized controlled trials
464. Effect of tirzepatide on blood pressure and lipids: A meta-analysis of randomized controlled trials
465. Establishing a 3d in vitro hepatic model mimicking physiologically relevant to in vivo state
466. Global burden of amphetamine, cannabis, cocaine and opioid use in 204 countries, 1990–2023: a Global Burden of Disease Study
467. Global burden of amphetamine, cannabis, cocaine and opioid use in 204 countries, 1990–2023: a Global Burden of Disease Study
468. Global burden of amphetamine, cannabis, cocaine and opioid use in 204 countries, 1990–2023: a Global Burden of Disease Study
469. Global burden of amphetamine, cannabis, cocaine and opioid use in 204 countries, 1990–2023: a Global Burden of Disease Study
470. Global burden of amphetamine, cannabis, cocaine and opioid use in 204 countries, 1990–2023: a Global Burden of Disease Study
471. Improved hepatoblast differentiation of human pluripotent stem cells by coffee bean derived graphene quantum dots
472. Tackling noncommunicable diseases in Africa through football: The case of Malawi
473. Investigating the Effects of Cognitive-Behavioral-Therapy-based Psychoeducation Program on University Students’ Automatic Thoughts, Perceived Stress, and Self-efficacy Levels
474. Fertility-sparing in cancer patients
475. Case report: Atypical teratoid/rhabdoid tumor of the lateral ventricle in a male adolescent (case-based review and diagnostic challenges in developing countries)
476. The right heart in patients with cancer. A scientific statement of the Heart Failure Association (HFA) of the ESC and the ESC Council of Cardio-Oncology
477. Global, regional, and national prevalence of child and adolescent overweight and obesity, 1990–2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021
478. Global, regional, and national prevalence of child and adolescent overweight and obesity, 1990–2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021
479. Global, regional, and national prevalence of child and adolescent overweight and obesity, 1990–2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021
480. Global, regional, and national prevalence of child and adolescent overweight and obesity, 1990–2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021
481. Global, regional, and national prevalence of child and adolescent overweight and obesity, 1990–2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021
482. Global, regional, and national prevalence of child and adolescent overweight and obesity, 1990–2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021
483. Global, regional, and national prevalence of child and adolescent overweight and obesity, 1990–2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021
484. Global, regional, and national prevalence of child and adolescent overweight and obesity, 1990–2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021
485. Global, regional, and national prevalence of child and adolescent overweight and obesity, 1990–2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021
486. Global, regional, and national prevalence of child and adolescent overweight and obesity, 1990–2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021
487. Global epidemiology of heart failure
488. Global epidemiology of heart failure
489. Mechano-Chemistry across Phase Transitions in Heated Albumin Protein Solutions
490. Health education competence: An investigation of the health education knowledge, skills and attitudes of nurses in Kazakhstan
491. Variations in the financial impact of the COVID-19 pandemic across 5 continents: A cross-sectional, individual level analysis
492. Chitosan-Based Biomaterials for Tissue Regeneration
493. Late diagnosis of CKD and associated survival after initiation of renal replacement therapy in Kazakhstan: analysis of nationwide electronic healthcare registry 2014–2019
494. Late diagnosis of CKD and associated survival after initiation of renal replacement therapy in Kazakhstan: analysis of nationwide electronic healthcare registry 2014–2019
495. Macrophage polarization in cardiac tissue repair following myocardial infarction
496. Recent advances in gene therapy for cardiac tissue regeneration
497. Anemia prevalence in women of reproductive age in low- and middle-income countries between 2000 and 2018
498. Anemia prevalence in women of reproductive age in low- and middle-income countries between 2000 and 2018
499. Anemia prevalence in women of reproductive age in low- and middle-income countries between 2000 and 2018
500. Anemia prevalence in women of reproductive age in low- and middle-income countries between 2000 and 2018
1 8 9 10 11 12 24